✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Mirum Pharmaceuticals, Inc.

Common Name
Mirum Pharmaceuticals
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
433
Ticker
MIRM
Exchange
Nasdaq
Description
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on rare and orphan diseases, with particular strength in liver and bile-acid related disorders. The company develops and commercializ...

Mirum Pharmaceuticals's Revenues Data

Explore Mirum Pharmaceuticals's total revenue by fiscal year, normalized to USD alongside the as-reported original currency value.

Metric2025202420232022-2019
Total Revenue(USD)
521,312,000a
336,888,000a
186,374,000a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Verified Sources Behind Mirum Pharmaceuticals’s Revenues Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Mirum Pharmaceuticals's 10-K 2025